Frank P. Muscolo

Controller at Trevi Therapeutics, Inc.

Frank P. Muscolo

Frank P. Muscolo

Controller at Trevi Therapeutics, Inc.

Biography

Mr. Frank P. Muscolo, CPA, is Secretary, Chief Accounting Officer & Controller at Penwest Pharmaceuticals Co.He received his undergraduate degree from The State University of New York.

Overview
RelSci Relationships

29

Birthday

1957

Age

61

Relationships
RelSci Relationships are individuals Frank P. Muscolo likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Trevi Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Trevi Therapeutics, Inc.

Relationship likelihood: Strong

Senior Director, Clinical Operations at Trevi Therapeutics, Inc.

Relationship likelihood: Average

Chief Financial Officer at Millendo Therapeutics, Inc.

Relationship likelihood: Average

President at Sun Valley Center for the Arts

Relationship likelihood: Average

Former Chief Scientific Officer & Senior Vice President at Penwest Pharmaceuticals Co.

Relationship likelihood: Average

Chief Executive Officer at Izun Pharmaceuticals Corp.

Relationship likelihood: Average

Former Director-Infrastructure Services at Hoffmann-La Roche, Inc.

Relationship likelihood: Average

Former Director-Formulations & Process Development at Penwest Pharmaceuticals Co.

Relationship likelihood: Average

Chief Financial Officer & Secretary at Sonoma Pharmaceuticals, Inc.

Relationship likelihood: Average

Paths to Frank P. Muscolo
Potential Connections via
Relationship Science
You
Frank P. Muscolo
Controller at Trevi Therapeutics, Inc.
Education

The State University of New York is the largest comprehensive university system in the United States, educating approximately 468,000 students in more than 7,500 degree and certificate programs, and more than 1.8 million NYS citizens in professional development and personal enrichment programs, on 64 college and university campuses. There are nearly 3 million SUNY alumni worldwide.

Career History
Controller
Current

Trevi Therapeutics, Inc. operates as a drug development company which focuses on developing Nalbuphine ER for the severe chronic itching. It is pursuing two conditions for clinical development: uremic pruritus and prurigo nodularis. Uremic pruritus is a persistent and debilitating itch in patients on dialysis that has been associated with increased mortality and Prurigo nodularis is a chronic dermatologic condition characterized by unsightly and itchy skin papules and nodules. The company was founded by Thomas R. Sciascia and Jennifer L. Good in 2011 and is headquartered in New Haven, CT.

Secretary, Chief Accounting Officer & Controller
1997 - Prior

Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY.

Other Affiliations

Frank P. Muscolo is affiliated with Trevi Therapeutics, Inc., Penwest Pharmaceuticals Co.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Frank P. Muscolo. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Frank P. Muscolo's profile does not indicate a business or promotional relationship of any kind between RelSci and Frank P. Muscolo.